Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BANK OF AMERICA CORP /DE/BAC · Entity 2801 | Director | April 29, 2009 | May 01, 2009 |
| CVS HEALTH CorpCVS · Entity 2884 | Director · Non-Executive Chairman | April 03, 2011 | April 05, 2011 |
| FIVE BELOW, INCFIVE · Entity 3393 | Director | May 04, 2026 | May 06, 2026 |
| PJT Partners Inc.PJT · Entity 3655 | Director | September 16, 2026 | September 18, 2026 |
| YUM BRANDS INCYUM · Entity 3067 | Director | February 10, 2017 | February 13, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BANK OF AMERICA CORP /DE/
Report date April 29, 2009 · Filed May 01, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Unit PlanSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 27,616.64 |
Reported balance
After 2009-03-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2009-03-27 · Grant · Acquired 37.58 · Balance 27,616.64 F1: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director. F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 31,130.07 |
Reported balance
After 2009-03-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2009-03-27 · Grant · Acquired 42.36 · Balance 31,130.07 F3: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F4: Phantom stock units may be settled in cash upon death or termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 49,563.25 |
Reported balance
After 2009-04-29 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2009-04-29 · Grant · Acquired 18,433.18 · Balance 49,563.25 F5: Stock units represent payment of the restricted stock portion of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3. F4: Phantom stock units may be settled in cash upon death or termination of service as a director. |
| Common StockSEC Table I · non-derivative | Direct | 57,260 |
Reported balance
Holding disclosure · report date 2009-04-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 57,260 |
| Common StockSEC Table I · non-derivative | Indirectby Ryan Family Foundation | 1,175 |
Reported balance
Holding disclosure · report date 2009-04-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,175 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse Trust | 804 |
Reported balance
Holding disclosure · report date 2009-04-29 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 804 |
Filing footnotes · ownership attribution and instrument terms
F1: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director.
F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director.
F3: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director.
F4: Phantom stock units may be settled in cash upon death or termination of service as a director.
F5: Stock units represent payment of the restricted stock portion of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3.
CVS HEALTH Corp
Report date April 03, 2011 · Filed April 05, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust As Beneficiary | 505,743 |
Reported balance
After 2011-01-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2011-01-07 · Gift · Disposed 11,150 · Balance 505,743 |
| Common StockSEC Table I · non-derivative | Direct | 1,156,701.9341 |
Reported balance
After 2011-04-03 transaction · row 2
1 source rowRow 2 · 2011-04-03 · Tax withholding · Disposed 27,468 · Balance 1,156,701.9341 F1: Surrender of shares in payment of withholding taxes due. |
| Common StockSEC Table I · non-derivative | IndirectBy Foundation | 67,040 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 67,040 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 481,337.4102 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 481,337.4102 |
| ESOP Common StockSEC Table I · non-derivative | IndirectBy ESOP | 8,322.4199 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 8,322.4199 |
| Stock UnitSEC Table I · non-derivative | Direct | 1,086,391.5831 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 1,086,391.5831 |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due.
FIVE BELOW, INC
Report date May 04, 2026 · Filed May 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 119,030 |
Reported balance
After 2026-05-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-04 · Grant · Acquired 96 · Balance 119,030 F1: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings. F2: Includes shares held by the reporting person's revocable trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings.
F2: Includes shares held by the reporting person's revocable trust.
PJT Partners Inc.
Report date September 16, 2026 · Filed September 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,940 |
Reported balance
After 2026-09-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-16 · Grant · Acquired 19 · Balance 11,940 F1: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.
F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units.
YUM BRANDS INC
Report date February 10, 2017 · Filed February 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,749 |
Reported balance
After 2017-02-10 transaction · row 1
1 source rowRow 1 · 2017-02-10 · Grant · Acquired 3,749 · Balance 3,749 |
| Common StockSEC Table I · non-derivative | IndirectRyan Trust | 38,706 |
Reported balance
Holding disclosure · report date 2017-02-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 38,706 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 20, 2018 Filed Jul 23, 2018 20:12 UTC | FIVE BELOW, INC FIVE · Entity 3393 | SaleCommon Stock | 35,000 | $103.25 | $3,613,592.50 |
DisclosureSEC source: 0001192482-18-000362 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,574 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.23 to $104.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 20:38 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-039234 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,828 Underlying: Class A Common Stock · 17 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.exercise_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.expiration_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. Read SEC document |
| June 19, 2018 Filed Jun 21, 2018 20:11 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 1,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000315 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,574 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 20:54 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 3,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035758 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,811 Underlying: Class A Common Stock · 3,176 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest in four substantially equal installments on each of August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019. The restricted stock units will be settled on the earlier of the termination of service of such director or the fifth anniversary of the grant date and will be settled in either Class A common stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F2 · derivative.expiration_date: The restricted stock units vest in four substantially equal installments on each of August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019. The restricted stock units will be settled on the earlier of the termination of service of such director or the fifth anniversary of the grant date and will be settled in either Class A common stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. Read SEC document |
| May 04, 2018 Filed May 8, 2018 20:05 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000179 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,560 F1 · price: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer of $23,750. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 21:53 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 16 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021505 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,635 Underlying: Class A Common Stock · 16 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.exercise_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.expiration_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:09 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 377 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000070 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,227 F1 · price: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer of $23,750. Read SEC document |
| December 20, 2017 Filed Dec 22, 2017 22:06 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-067099 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,619 Underlying: Class A Common Stock · 18 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · derivative.exercise_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.expiration_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 20:32 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-17-000265 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,850 Read SEC document |
| September 21, 2017 Filed Sep 22, 2017 20:39 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 22 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-053722 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,601 Underlying: Class A Common Stock · 22 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · derivative.exercise_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.expiration_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 21:48 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 471 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-17-000209 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,422 Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 20:36 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041670 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,579 Underlying: Class A Common Stock · 21 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · derivative.exercise_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.expiration_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 20:16 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 2,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-17-000179 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,951 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:31 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 3,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037260 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,558 Underlying: Class A Common Stock · 3,142 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest in four substantially equal installments on each of August 31, 2017, November 30, 2017, February 28, 2018 and May 31, 2018. The restricted stock units will be settled on the earlier of the termination of service of such director or the fifth anniversary of the grant date and will be settled in either Class A common stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. F2 · derivative.expiration_date: The restricted stock units vest in four substantially equal installments on each of August 31, 2017, November 30, 2017, February 28, 2018 and May 31, 2018. The restricted stock units will be settled on the earlier of the termination of service of such director or the fifth anniversary of the grant date and will be settled in either Class A common stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee. Read SEC document |
| April 28, 2017 Filed May 2, 2017 21:50 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 432 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-17-000113 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,873 F1 · price: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer of $21,250. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 20:32 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022951 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,416 Underlying: Class A Common Stock · 19 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.exercise_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.expiration_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 16:22 UTC | YUM BRANDS INC YUM · Entity 3067 | GrantCommon Stock | 3,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005154 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,749 Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 21:05 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 565 | $37.60 | $21,244.00 |
DisclosureSEC source: 0001192482-17-000024 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,441 F1 · price: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer of $21,250. Read SEC document |
| December 21, 2016 Filed Dec 22, 2016 21:52 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-156551 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,397 Underlying: Class A common stock · 21 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.exercise_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.expiration_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. Read SEC document |
| October 28, 2016 Filed Oct 31, 2016 21:16 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 569 | $37.29 | $21,218.01 |
DisclosureSEC source: 0001192482-16-000743 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,876 F1 · price: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer of $21,250. Read SEC document |
| October 28, 2016 Filed Oct 31, 2016 20:55 UTC | FIVE BELOW, INC FIVE · Entity 3393 | GrantCommon Stock | 569 | $37.29 | $21,218.01 |
DisclosureSEC source: 0001192482-16-000739 · edgar.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,876 F1 · price: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer of $21,250. Read SEC document |
| October 24, 2016 Filed Oct 31, 2016 16:41 UTC | YUM BRANDS INC YUM · Entity 3067 | GiftCommon Stock | 17,200 | $87.47 | $1,504,398.00 |
DisclosureSEC source: 0001127602-16-065515 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Ryan Trust Disclosed balance after: 38,706 Read SEC document |
| September 21, 2016 Filed Sep 23, 2016 20:15 UTC | PJT Partners Inc. PJT · Entity 3655 | GrantRestricted Stock Units · Derivative | 26 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-142593 · doc4.xml · derivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,376 Underlying: Class A common stock · 26 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.exercise_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. F2 · derivative.expiration_date: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. Read SEC document |
| April 03, 2011 Filed Apr 5, 2011 20:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 27,468 | $34.96 | $960,281.28 |
DisclosureSEC source: 0001127602-11-012384 · form4.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Non-Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,156,701.9341 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| January 07, 2011 Filed Apr 5, 2011 20:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 11,150 | $35.05 | $390,807.50 |
DisclosureSEC source: 0001127602-11-012384 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Non-Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust As Beneficiary Disclosed balance after: 505,743 Read SEC document |
| December 31, 2010 Filed Jan 4, 2011 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 27,554 | $34.77 | $958,052.58 |
DisclosureSEC source: 0001127602-11-000624 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,088,624.8778 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| December 17, 2010 Filed Jan 4, 2011 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 4,375 | $34.40 | $150,500.00 |
DisclosureSEC source: 0001127602-11-000624 · form4.xml · nonDerivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust As Beneficiary Disclosed balance after: 516,893 Read SEC document |
| December 09, 2010 Filed Jan 4, 2011 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 4,525 | $33.59 | $151,994.75 |
DisclosureSEC source: 0001127602-11-000624 · form4.xml · nonDerivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust As Beneficiary Disclosed balance after: 482,026 Read SEC document |
| December 09, 2010 Filed Jan 4, 2011 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 19,990 | $33.59 | $671,464.10 |
DisclosureSEC source: 0001127602-11-000624 · form4.xml · nonDerivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Foundation Disclosed balance after: 67,040 Read SEC document |
| December 09, 2010 Filed Jan 4, 2011 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 19,990 | $33.59 | $671,464.10 |
DisclosureSEC source: 0001127602-11-000624 · form4.xml · nonDerivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust As Beneficiary Disclosed balance after: 486,551 Read SEC document |
| December 08, 2010 Filed Jan 4, 2011 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 10,050 | $33.30 | $334,665.00 |
DisclosureSEC source: 0001127602-11-000624 · form4.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Foundation Disclosed balance after: 47,050 Read SEC document |
| December 08, 2010 Filed Jan 4, 2011 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 10,050 | $33.30 | $334,665.00 |
DisclosureSEC source: 0001127602-11-000624 · form4.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust As Beneficiary Disclosed balance after: 506,541 Read SEC document |
| December 07, 2010 Filed Dec 9, 2010 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 400,000 | $0.00 Strike: $22.45 | $0.00 |
DisclosureSEC source: 0001127602-10-030090 · form4.xml · derivative · entry 11 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires 2012-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2010 Filed Dec 9, 2010 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 1,012,124 | $0.00 Strike: $14.96 | $0.00 |
DisclosureSEC source: 0001127602-10-030090 · form4.xml · derivative · entry 10 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,012,124 shares Expires 2012-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2010 Filed Dec 9, 2010 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 400,000 | $33.06 | $13,222,960.00 |
DisclosureSEC source: 0001127602-10-030090 · form4.xml · nonDerivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 764,682.8778 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $33.00 and $33.08 per share. Read SEC document |
| December 07, 2010 Filed Dec 9, 2010 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 400,000 | $22.45 | $8,978,000.00 |
DisclosureSEC source: 0001127602-10-030090 · form4.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164,682.8778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2010 Filed Dec 9, 2010 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 1,012,124 | $33.06 | $33,458,187.92 |
DisclosureSEC source: 0001127602-10-030090 · form4.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 764,682.8778 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $33.00 and $33.08 per share. Read SEC document |
| December 07, 2010 Filed Dec 9, 2010 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 1,012,124 | $14.96 | $15,143,905.35 |
DisclosureSEC source: 0001127602-10-030090 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,776,806.8778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2010 Filed Nov 10, 2010 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 500,000 | $0.00 Strike: $30.26 | $0.00 |
DisclosureSEC source: 0001127602-10-027660 · form4.xml · derivative · entry 11 RYAN THOMAS M · CIK 0001194416 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2011-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2010 Filed Nov 10, 2010 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 400,000 | $0.00 Strike: $17.67 | $0.00 |
DisclosureSEC source: 0001127602-10-027660 · form4.xml · derivative · entry 10 RYAN THOMAS M · CIK 0001194416 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires 2011-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2010 Filed Nov 10, 2010 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 500,000 | $31.02 | $15,508,900.00 |
DisclosureSEC source: 0001127602-10-027660 · form4.xml · nonDerivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,587.8778 F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $31.00 and $31.07 per share. Read SEC document |
| November 08, 2010 Filed Nov 10, 2010 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 500,000 | $30.26 | $15,131,250.00 |
DisclosureSEC source: 0001127602-10-027660 · form4.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,256,587.8778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2010 Filed Nov 10, 2010 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 400,000 | $30.93 | $12,373,960.00 |
DisclosureSEC source: 0001127602-10-027660 · form4.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,587.8778 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $30.85 and $30.99 per share. Read SEC document |
| November 08, 2010 Filed Nov 10, 2010 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 400,000 | $17.67 | $7,067,000.00 |
DisclosureSEC source: 0001127602-10-027660 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,156,587.8778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2010 Filed Apr 5, 2010 22:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 25,248 | $36.23 | $914,735.04 |
DisclosureSEC source: 0001127602-10-010563 · form4.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 821,345.8778 F2 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 446,215 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-10-010563 · form4.xml · derivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,215 Underlying: Common Stock · 446,215 shares Expires 2017-04-01 F3 · shares: Option becomes exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 120,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-010563 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 672,828.4102 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 4/1/2013 and 50% on 4/1/2015. Read SEC document |
| February 17, 2010 Filed Feb 19, 2010 21:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 36,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-005633 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788,487.8778 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan. Read SEC document |
| November 12, 2009 Filed Nov 13, 2009 19:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 7,000 | $29.99 | $209,930.00 |
DisclosureSEC source: 0001127602-09-022548 · form4.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust As Beneficiary Disclosed balance after: 638,024.7301 Read SEC document |
| November 11, 2009 Filed Nov 13, 2009 19:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 10,000 | $29.94 | $299,412.00 |
DisclosureSEC source: 0001127602-09-022548 · form4.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust As Beneficiary Disclosed balance after: 631,024.7301 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.